RAUL VILLARREAL
Allopathic & Osteopathic Physicians|Allergy & Immunology SAN ANTONIO, TX NPI 1083008908
Browse related groups: Allopathic & Osteopathic Physicians|Allergy & Immunology TX GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$14,690.09
- Category: General Payments
- Program years: PY2018–2024
- Record count: 556
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,433.32 across 108 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,307.33 | 106 |
| Education | $125.99 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $605.48 | 37 |
| Acerta Pharma LLC | $325.95 | 11 |
| SANOFI-AVENTIS U.S. LLC | $318.83 | 11 |
| GENZYME CORPORATION | $281.18 | 10 |
| CSL Behring | $157.36 | 6 |
| Mylan Specialty L.P. | $100.08 | 5 |
| Genentech USA, Inc. | $93.97 | 5 |
| Regeneron Healthcare Solutions, Inc. | $92.41 | 3 |
| Grifols USA, LLC | $74.65 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.37 | 3 |
| Incyte Corporation | $58.97 | 1 |
| PFIZER INC. | $47.61 | 3 |
| Galderma Laboratories, L.P. | $38.96 | 1 |
| Lilly USA, LLC | $30.74 | 1 |
| Pharming Healthcare, Inc. | $26.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.24 | 1 |
| Genentech, Inc. | $20.41 | 1 |
| Kaleo, Inc. | $20.28 | 1 |
| Octapharma USA, Inc. | $20.00 | 1 |
| Blueprint Medicines Corporation | $18.47 | 1 |
| Hikma Pharmaceuticals USA | $13.36 | 1 |
By program year
Records — PY2024 (108)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.